Australia markets closed
  • ALL ORDS

    7,255.80
    +16.40 (+0.23%)
     
  • AUD/USD

    0.7742
    -0.0043 (-0.56%)
     
  • ASX 200

    7,023.60
    +9.40 (+0.13%)
     
  • OIL

    64.97
    -0.40 (-0.61%)
     
  • GOLD

    1,847.40
    +9.30 (+0.51%)
     
  • BTC-AUD

    57,961.29
    -5,354.25 (-8.46%)
     
  • CMC Crypto 200

    1,252.96
    -105.60 (-7.77%)
     

Market Recap: Tuesday, April 13

  • Oops!
    Something went wrong.
    Please try again later.

Stocks traded mixed on Tuesday after U.S. federal health officials called for a pause in the rollout of Johnson & Johnson's COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation. The Dow dipped, extending losses from the pre-market session following the joint announcement between the U.S. Food and Drug Administration and Centers for Disease Control and Prevention, which could complicate the vaccine distribution process as the country paces toward achieving herd immunity. The Nasdaq gained as technology shares advanced, while the S&P 500 was little changed. George Young, PM, Villere Balanced Fund and Brigg Macadam Founding Partner Greg Swenson joined Yahoo Finance Live to discuss.